Anti-Depressants Flashcards

1
Q

Inhibits SERT increases concentration of 5HT at synaptic membrane

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1st line agents for depression, GAD, OCD and Bulemia

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SSRIs (4)

A

Fluoxetine
Paroxetine
Sertraline
Citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Short acting SSRIs with discontinuation syndrome (flu like dizziness, fatigue, nausea 1-2d)

A

Paroxetine

Sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SSRI SE (5)

A
Hyponatremia
Inc SIADH
Dec sexual dysfunction
Weight gain
Drowsiness
Insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Inhibits presynaptic reuptake of NE and 5HT

A

SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Apart from GAD, MDD, PTSD this relieves pain disorders

A

SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SNRI examples (2)

A

Venlafaxine

Duloxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Used for diabetic neuropathy

A

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Used for chronic, neuropathic pain, OA, LBP

A

Duloxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Notorious AE of SNRI (also similar with SSRI) because of noradrenergic activity

A

May cause HTN and HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSRI and SNRIs take how long to take effect

A

1-2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Wait for how long before dismissing as inadequate treatment response

A

8-12 w

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AE of SSRIs ans SNRIs toxicity

A

Serotonin Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Serotonin syndrome sx (5)

A
Autonomic instability
Agitation
Hyperkalemia
Hyperreflexia
Clonus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neuroleptic Malignant Syndrome (2) by dopamine blocking agents

A

Hyporeflexia

Rigidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Serotonin syndrome antidote

A

Cryoheptadine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blocks NET and SERT at the presynaptic membrane during reuptake

A

TCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2nd or 3rd line drug for MDD if unresponsive to others

A

TCAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

TCAs (5)

A
Imipramine
Desipramine
Clomipramine
Amitryptiline
Nortryptiline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amine with less anticholinergic effect (2)

A

Desipiramine

Nortryptiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tx for OCD

A

Clomipramine

23
Q

Tx for migraine with most potent anticholinergic effect

A

Amitryptiline

24
Q

TCA use (3)

A

Depression resistant to tx
Migraine prevention
Pain disorder

25
TCA SE (4)
Sexual dysfunction Anticholinergic property Cardiotoxicity (depressant) Weight gain (antihistamine)
26
Ventricular arrhythmia (torsade, widened QRS) from TCA antidote
Na bicarbonate
27
TCA poison:
Seizure antagonist
28
Increases transmission of norepinephrine, serotonin and dopamine
MOA Inhibitors
29
MAO Inhibitors MOA (2)
MAO A - deaminates serotonin, NE and dopamine | MAO B - demaminates dopamine preferentially
30
MAOIs are especially used for depression with (2):
1 hyperphagia | 2 hypersomnia
31
MAOI examples (4)
Tranylcypromine Phenelzine Isocarboxazid Selegiline
32
Non selective, irreversible MAOI
Tranylcypromine Phenelzine Isocarboxazid
33
Selective inhibtor of MAO B useful in PD
Selegiline
34
Discontinue SSRIs and SNRIs at least weeks before giving MAOI
2 week wash off period
35
MAO I SE (3)
orthostatic hypotension weight gain Most sexually debillitating
36
MAOIs should not be taken with rich food
tyramine
37
Tyramine interacts with MAOIs by
MAOIs prevent metabolism of tyramine increasing risk for sympathomimetic effects
38
Antidote HTN induced by tyramine toxicity
Phentolamine
39
Phentolamine MOA
alpha 1 and 2 block
40
Used for MDD resistant with first and second lines
Atypical antidepressant
41
inhibits reuptake of Norepinephrine and Dopamine has no effect on serotonin but has CNS activating effect
Bupropion
42
User in depression with hypersomnolence, low energy and in tobacco dependence Nicotine dependence and withdrawal symptoms
Bupropion
43
Bupropion has no SE
sexual dysfunction | weight gain
44
Bupropion is CI in
Bulemics
45
Bupropion SE
seizure
46
a2 blocker in presynaptic membrane used in depression with insomnia post synaptic serotonin blocking activity antihistamine activity Inc noradrenergic and serotonergic neurotransmission
Mirtazipine
47
Mirtazipine can cause this se because of serotonin receptor 2, 3 blockade
weight gain
48
Antagonist at serotonin 5HT2A post synaptic receptor and weakly inhibits serotonin reuptake Antagonist at H1 Antagonist at a1 postsynaptic
Trazodone | Nefazodone
49
May cause priapism due to vasodilatory effect
Mirtazipine
50
Persistent erection of >4 hours not associated with sexual dysfunction
Priapism
51
Trazodone should be used cautiously in patients with (2)
Sickle cell disease | Multiple myeloma
52
Trazodone specifically blocks the
5ht2A receptor
53
Inhibits recycling of neuronal membrane inositol lipids (activation of PLC to IP3 and DAG) Inhibits inositol phosphatase enzymes that regenerates PIP2 Inhibits glycogen synthase kinase 3 (GSK3) mimicking Wnt pathway (inhibits axon remodelling, synapse formation and neurogenesis) For depression and bipolar disorder Narrow therapeutic index Mood stabilizer
Lithium
54
Activation of GSK 3 is associated with
Bipolar disorder